from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3077/-

LFCtreatmentdescriptionclass of inhibitor

-0.444

Amikacinug/mL Amikacintranslation

0.408

Cap5-10ug/mL Capreomycintranslation

-0.335

Rox10-50 ug/mL Roxithromycintranslation

-0.081

SM2-5 ug/mL Streptomycintranslation

-0.983

Tet5-10 ug/mL Tetracyclinetranslation

0.079

Rif0.2-5ug/mL Rifampicintranscription

0.277

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.107

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.197

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.313

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.309

Clofazimine10-13 ug/mL Clofaziminerespiration

0.017

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.294

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.190

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.260

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.432

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.597

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.357

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.085

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.685

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.599

KCN5-20 ug/mL Potassium cyaniderespiration

-0.367

NaN30.2-2 mM Sodium aziderespiration

-0.104

Nigericin50 uM Nigericinrespiration

-0.811

TRC10-150 ug/mL Triclosanrespiration

-0.129

TRZ10-25 ug/mL Thioridazinerespiration

-0.789

Valinomycin0.5-10 uM Valinomycinrespiration

0.435

ZnSO42 mM ZnSO4respiration

-0.627

menadione6-10 ug/mL Menadionerespiration

1.214

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.406

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.914

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.274

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.306

NRP_1Non-replicating persistence stage 1dosRassociated

0.734

Amp0.2mg/mL AmpicillincellWall

0.481

Cephalexin20-100 ug/mL CephalexincellWall

-0.012

Cerulenin0.32-5 ug/mL CerulenincellWall

1.388

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.196

EMB10-20 ug/mL EthambutolcellWall

0.680

Eta12-40 ug/mL EthionamidecellWall

0.427

INH0.2-0.4 ug/mL IsoniazidcellWall

0.427

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.492

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.705

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.644

BZA0.12 mg/mL BenzamidearomaticAmides

-1.297

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.583

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.321

H2O24 mM hydrogen peroxideDNAdamaging

1.077

Levo10 ug/mL LevofloxacinDNAdamaging

0.140

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.024

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.559

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.022

UVUV-irradiationDNAdamaging

-0.388

ARP41-4 ug/mL Antitubercular compound ARP4?

0.897

Antimycin12.5-50 ug/mL Antimycin A?

0.363

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.374

PA_110-50 ug/mL Antitubercular compound PA-1?

0.644

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.353

PA8240.2-2 ug/mL PA-824?

-0.315

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.045

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.147

Verapamil50 uM Verapamil?

0.264

mercaptoethanol2 mM 2-Mercaptoethanol?

0.485

methoxatin10-20 ug/mL Methoxatin?